Showing results (61-70 of 155) with videos related to
Sort By:
Pageof 16
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 30, 2012
Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a reviewAshlee N Ford Versypt, Daniel W Pack, Richard D BraatzCancer Chemotherapy and Pharmacology|March 30, 2007
Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycinJaime A Yáñez, M Laird Forrest, Yusuke Ohgami, et al.Advanced Drug Delivery Reviews|July 2, 2011
Advances in lymphatic imaging and drug deliverySatish K Nune, Padmaja Gunda, Bharat K Majeti, et al.Advanced Drug Delivery Reviews|April 24, 2009
Effects of nanomaterial physicochemical properties on in vivo toxicityKristin L Aillon, Yumei Xie, Nashwa El-Gendy, et al.BAOJ Pharmaceutical Sciences|January 13, 2016
A Lanthanum-Tagged Chemotherapeutic Agent HA-Pt to Track the In Vivo Distribution of Hyaluronic Acid ComplexesTi Zhang, Qiuhong Yang, W C Forrest, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2006
Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micellesM Laird Forrest, Anni Zhao, Chee-Youb Won, et al.Applied Spectroscopy|August 17, 2016
Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and TissuesTi Zhang, Shuang Cai, Wai Chee Forrest, et al.Journal of Pharmaceutical Sciences|June 20, 2019
Effect of Iron Oxide Nanoparticles on the Oxidation and Secondary Structure of Growth HormoneNinad Varkhede, Björn-Hendrik Peters, Yangjie Wei, et al.Molecular Pharmaceutics|October 25, 2022
Glatiramer Acetate Complexed with CpG as Intratumoral Immunotherapy in Combination with Anti-PD-1Aric Huang, Chad Groer, Ruolin Lu, et al.Molecular Cancer Research : MCR|March 17, 2018
Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP InhibitionPingping Fang, Jill A Madden, Lisa Neums, et al.Pageof 16